P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In

 

News Categories

 

 

 

Correction

An article in the September issue of P&T, page 502, incorrectly stated that the FDA considers Vascepa to be a new chemical entity (NCE). In fact, the FDA has not yet decided whether to grant the drug new chemical entity marketing exclusivity. P&T regrets the error.

More stories